3MODELL B, DARLISON M. Global epidemiology of haemoglobin disorders and derived service indicators [ J ]. Bull World Health Organ, 2008, 86(6) : 480 -487.
4National Hemoglobinopathy Cooperative Study Group. A survey of hemoglobinopathies in 600 000 peoples from 20 provinces, autonomous regions and municipalities[ J]. National Med J Chin, 1983, 64 : 382 - 385.
5ZENG Y T, HUANG S Z. Disorders of haemoglobin in China[ J]. J Med Genet, 1987, 24(10) : 578 -583.
6XU X M, ZHOU Y Q, LUO G X, et al. The prevalence and spec- trum of alpha and beta thalassaemia in Guangdong Province : impli- cations for the future health burden and populalion screening[ J]. J Clin Pathol, 2004, 57(5) : 517 -522.
7SRIVORAKUN H, FUCHAROEN G, CHANGTRAKUL Y, et al.Thalassemia and hemoglobinopathies in Southeast Asian newborns: diagnostic assessment using capillary electrophoresis system [ J ]. Clin Biochem, 2011, 44(5/6) : 406 -411.
8WAGNER S C, DE CASTRO S M, GONZALEZ T P, et al. Neonatal screening for hemoglobinopathies: results of a public health system in South Brazil[ J]. Genet Test Mol Biomarkers, 2010, 14 (4) : 565 -569.
9GIORDANO P C. Prospective and retrospective primary prevention of hemoglobinopathies in multiethnic societies[J]. Clin Biochem, 2009, 42(18) : 1757 -1766.
10WANG J, ZHOU S, HUANG W, et al. CE - based analysis of hemoglobin and its applications in clinical analysis [ J ]. Electrophoresis, 2006, 27 ( 15 ) : 3108 - 3124.
